What can the industry do to facilitate remote and distant assessments? Are distant assessments ‘here for now’ or ‘here forever’? Will the future be a ‘Hybrid model’? Will onsite inspections be prioritized once it is safe to travel and what framework will be applied to inspections?
These questions and more will be answered during the 2021 ISPE Global Pharmaceutical Regulatory Summit on 28 April. Watch this video to hear from Thomas Hartman, President & CEO, ISPE, as he highlights featured global health authorities and the in-depth, interactive discussions you can't join anywhere else.